Berlin, Berlin, Germany
Vivira. Einfach bewegen. Deine App auf Rezept bei Rückenschmerzen. Vivira ist eine dauerhaft BfArM-gelistete Digitale Gesundheitsanwendung (DiGA) zur Reduktion von Rückenschmerzen, die von allen Ärzt*innen in Deutschland verordnet werden kann. Alle gesetzlichen Krankenkassen und zunehmend auch private Krankenversicherungen übernehmen die Kosten. Vivira ist die erste und bislang einzige digitale Gesundheitsanwendung in Deutschland, die auf Basis ihrer klinischen Evidenz als mögliche Alternative zur Physiotherapie zur Behandlung von Rückenschmerzen Zulassung durch das BfArM in der Regelversorgung erhalten hat.
Vivira, a Prescription Digital Therapeutic (PDT/DiGA), provides personalized movement therapy for patients with musculoskeletal pain. Vivira was one of the first Digital Therapeutics (DTx) to achieve general reimbursement in the German healthcare system in October 2020. From 2020 to 2025, Vivira was the most often doctor-prescribed, BfArM-listed Digital MSK Therapeutic in Germany. In 2022, based on Vivira's strong clinical evidence (RCT), showing superiority to physiotherapy in both pain reduction and pain medication reduction, Vivira achieved permanent BfArM-listing. All medical doctors in Germany can prescribe Vivira, all public health insurances (covering 93% of the German population) cover the costs. Most private health insurances also cover the costs.
Philip Heimann co-founded XCSE in 2011 to provide high quality service and sales contact center outsourcing for e-commerce clients with a focus on digital service delivery and online sales support across Europe in 7 European languages. Abramo Customer Care acquired XCSE Experience Customer Service end of 2014.
Lead teams to deliver recommendations to senior leadership in consumer and industrial goods, travel and logistics, and services industries, with a focus on service and sales operations. Provided leadership, business judgement and problem solving expertise to senior managers to resolve their most important strategic and operational issues across Europe and the U.S.